New 'Smart Drug' Reduces Site-Specific Inflammation Avoiding Side Effects

by Bidita Debnath on  July 23, 2015 at 11:14 PM Drug News   - G J E 4
Ben-Gurion University researchers have developed a dynamic "smart" drug that targets inflammation in a site-specific manner and could enhance the body's natural ability to fight infection and reduce side-effects.
New 'Smart Drug' Reduces Site-Specific Inflammation Avoiding Side Effects
New 'Smart Drug' Reduces Site-Specific Inflammation Avoiding Side Effects

"This development is important because inhibition of inflammation in a non-specific manner reduces the natural ability to fight infections and is a common side effect of anti-inflammatory biologic therapeutics," said one of the researchers Peleg Rider from Ben-Gurion University of the Negev (BGU), Israel.

The uniqueness of this novel anti-inflammatory molecule, reported in the current issue of Journal of Immunology, can be found in a singular property. When injected, it acts as a non-active drug. However, a localized site with excessive inflammation will activate it, the study said.

Most other anti-inflammatory agents effectively inhibit inflammatory processes, though in a non-specific manner and in areas that include sites of necessary normal inflammatory homeostasis. The researchers demonstrated their findings in a mouse model of local inflammation.

"The beauty of this invention lies in the use of a known natural biological code. We mimicked a natural process that occurs during inflammation," Rider said. "Upon resolution of inflammation, the activation of the protein is also reduced and side effects are avoided," he added.

Source: IANS

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

More News on: